Aradigm
HomeAboutProductsTechnologiesInvestorsCareers
Press Releases

Investor Relations

Events & Presentations

Corporate Governance

Financial Information

Stock Information

Contact Us


All Releases
View Summary Results from Non-Tuberculous Mycobacteria (NTM) Study Using Aradigm's Liposomal Ciprofloxacin to be Presented at the American Thoracic Society 2014 International Conference
Apr 15, 2014
PDF 14.9 KB Add to Briefcase
View Summary Aradigm Announces Fourth Quarter 2013 and Full Year Financial Results
Mar 13, 2014
PDF 29.7 KB Add to Briefcase
View Summary Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2014 on February 11
Feb 4, 2014
PDF 11.7 KB Add to Briefcase
View Summary Aradigm to Present at Biotech Showcase 2014 on January 14
Jan 8, 2014
PDF 11.6 KB Add to Briefcase
View Summary Aradigm Announces Appointment of Dr. Juergen Froehlich as Chief Medical Officer
Nov 19, 2013
PDF 14.8 KB Add to Briefcase
View Summary Aradigm Announces Third Quarter 2013 Financial Results
Oct 28, 2013
PDF 24.5 KB Add to Briefcase
View Summary Aradigm Announces Changes to Its Board of Directors
Sep 18, 2013
PDF 18.9 KB Add to Briefcase
View Summary Sigma-Tau PharmaSource, Inc. and Aradigm Corporation Sign Manufacturing Agreement for the Clinical and Commercial Supply of Pulmaquin
Sep 16, 2013
PDF 15.7 KB Add to Briefcase
View Summary Aradigm to Present at the Stifel Nicolaus 2013 Healthcare Conference
Sep 9, 2013
PDF 11.5 KB Add to Briefcase
View Summary Grifols and Aradigm Corporation Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin®
Aug 28, 2013
PDF 19.4 KB Add to Briefcase
View Summary Aradigm Announces Second Quarter 2013 Financial Results
Aug 8, 2013
PDF 22.9 KB Add to Briefcase
View Summary Aradigm Awarded NIH Grant to Investigate New Methods of Diagnoses of Aspirations of Gastrointestinal Contents into the Respiratory Tract with Scientists at UC San Francisco
Aug 7, 2013
PDF 13.9 KB Add to Briefcase
View Summary Aradigm Awarded NIH Grant to Investigate the Treatment of Pulmonary Non-Tuberculous Mycobacterial (PNTM) Infections with Pulmaquin and Lipoquin
Aug 1, 2013
PDF 15.0 KB Add to Briefcase
View Summary Aradigm Shareholders Approve Collaboration Transaction With Grifols, S.A. to Develop and Commercialize Pulmaquin
Jul 16, 2013
PDF 17.8 KB Add to Briefcase
View Summary Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin™
May 21, 2013
PDF 19.8 KB Add to Briefcase
View Summary Aradigm Announces First Quarter 2013 Financial Results
May 14, 2013
PDF 18.6 KB Add to Briefcase
View Summary Aradigm Announces Fourth Quarter 2012 and Full Year Financial Results
Mar 26, 2013
PDF 26.2 KB Add to Briefcase
View Summary Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2013 on February 12
Feb 6, 2013
PDF 11.6 KB Add to Briefcase
View Summary Aradigm to Present at Biotech Showcase 2013 on January 9
Jan 3, 2013
PDF 11.5 KB Add to Briefcase
View Summary Aradigm Announces Private Placement for $6 Million
Dec 12, 2012
PDF 14.3 KB Add to Briefcase
Showing 1-20 of 169 Page: 1 2 3 ... 9  Next 20
= add release to Briefcase
CONTACT NEWS & EVENTS LEGAL SITE MAP ©2014 Aradigm Corporation. All Rights Reserved.